Who Exports Azithromycin from India — 853 Suppliers Behind a $184.3M Market
India's azithromycin export market is supplied by 853 active exporters who collectively shipped $184.3M across 15,000 shipments. LINCOLN PHARMACEUTICALS LTD leads with a 10.4% market share, followed by LUPIN LIMITED and MICRO LABS LIMITED. The top 5 suppliers together control 32.6% of total export value, reflecting a moderately competitive market structure.
Top Azithromycin Exporters from India — Ranked by Export Value
LINCOLN PHARMACEUTICALS LTD is the leading azithromycin exporter from India, holding a 10.4% share of the $184.3M market across 15,000 shipments from 853 exporters. The top 5 suppliers — LINCOLN PHARMACEUTICALS LTD, LUPIN LIMITED, MICRO LABS LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, CIPLA LIMITED — collectively control 32.6% of total export value, indicating a competitive market. Individual shares are: LINCOLN PHARMACEUTICALS LTD (10.4%), LUPIN LIMITED (6.7%), MICRO LABS LIMITED (5.7%), ALEMBIC PHARMACEUTICALS LIMITED (5.2%), CIPLA LIMITED (4.6%).
Top Azithromycin Exporters from India
Ranked by export value · 853 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | LINCOLN PHARMACEUTICALS LTD AZITHROMYCIN ORAL SUSPENSION 200 MG/5 MLAZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN ORAL SUSPENSION 200 MG/ 5 | $19.2M | 16 | 10.4% |
| 2 | LUPIN LIMITED AZITHROMYCIN FOR INJECTION USP 500MG/VIALAZITHROMYCIN 250MG TABLETS (AZITHROMYCINAZITHROMYCIN USP 250MG 3X1X6T BLI APUS | $12.3M | 2 | 6.7% |
| 3 | MICRO LABS LIMITED AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN ORAL SUSPENSION 200 MG/ 5AZIRID E | $10.6M | 17 | 5.7% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED AZITHROMYCIN FOR INJECTION USP 500MG/VIALAZITHROMYCIN 250MG TABLETS (AZITHROMYCINAZITHROMYCIN USP 250MG 3X1X6T BLI APUS | $9.6M | 2 | 5.2% |
| 5 | CIPLA LIMITED AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZIRID EAZICURE 500MG CPR B/3 (AZITHROMYCIN TAB | $8.4M | 12 | 4.6% |
| 6 | JUBILANT GENERICS LIMITED AZITHROMYCIN TABLETS 500 MG. EACH TABLETAZITHROMYCIN 500MG FCT 1X3 S UNICORNSAFRAZITHROMYCIN 500MG FCT 1X3'S UNICORN SAF | $6.9M | 14 | 3.8% |
| 7 | ZYDUS LIFESCIENCES LIMITED AZICURE 500MG CPR B/3 (AZITHROMYCIN TABAZEE 500MG TABLET (AZITHROMYCIN DIHYDRATAZITHROMYCIN TABLETS 500 MG. EACH TABLET | $6.0M | 8 | 3.3% |
| 8 | AJANTA PHARMA LIMITED AZITHROMYCIN ORAL SUSPENSION 200 MG/5 MLAZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN ORAL SUSPENSION 200 MG/ 5 | $5.8M | 20 | 3.2% |
| 9 | ANANT PHARMACEUTICS AZIMAX-500(AZITHROMYCIN TABLET USP 500MGAZIMAP 500 AZITHROMYCIN 500MG./TABLET PAEACH TABLET CONTAINS AZITHROMYCIN 500 MG | $4.9M | 1 | 2.7% |
| 10 | MACLEODS PHARMACEUTICALS LTD AZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN ORAL SUSPENSION 200 MG/ 5AZIMAX-500(AZITHROMYCIN TABLET USP 500MG | $4.6M | 14 | 2.5% |
| 11 | EUGIA PHARMA SPECIALITIES LIMITED AZITHROMYCIN FOR INJECTION USP 500MG/VIALAZITHROMYCIN 250MG TABLETS (AZITHROMYCINAZITHROMYCIN USP 250MG 3X1X6T BLI APUS | $3.6M | 2 | 2.0% |
| 12 | GLAND PHARMA LIMITED AZITHROMYCIN FOR INJECTION USP 500MG/VIALAZITHROMYCIN 250MG TABLETS (AZITHROMYCINAZITHROMYCIN USP 250MG 3X1X6T BLI APUS | $3.3M | 3 | 1.8% |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $3.1M | 10 | 1.7% |
| 14 | SCOTT EDIL PHARMACIA LIMITED AZITHROMYCIN ORAL SUSPENSION 200 MG/5 MLAZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN ORAL SUSPENSION 200 MG/ 5 | $2.7M | 18 | 1.5% |
| 15 | MEDOPHARM AZITHROMYCIN ORAL SUSPENSION 200 MG/5 MLAZILIDE DRY SYRUP (AZITHROMYCIN FOR ORALAZITHROMYCIN TABLETS USP | $2.3M | 23 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Azithromycin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Lincoln Pharmaceuticals Limited | Not Listed | Yes | Yes | Not Listed | Manufacturing facility approved by EU GMP and WHO GMP. |
| Lupin Limited | Approved | Yes | Yes | Not Listed | Received FDA approval for Raltegravir Tablets USP, 600 mg in May 2025. |
| Cipla Limited | Approved | Yes | Yes | Not Listed | Received FDA approval for Acyclovir Cream, 5% in May 2025. |
| Alembic Pharmaceuticals Limited | Approved | Yes | Yes | 223 | Received multiple FDA approvals between 2024 and 2025, including for Doxorubicin |
| Zydus Lifesciences Limited | Approved | Yes | Yes | Not Listed | Manufactures a wide range of pharmaceuticals with FDA approvals. |
| Micro Labs Limited | Not Listed | Yes | Yes | Not Listed | Operates GMP-compliant manufacturing facilities catering to regulated markets. |
| Macleods Pharmaceuticals Ltd | Approved | Yes | Yes | Not Listed | Manufactures a wide range of pharmaceuticals with FDA approvals. |
| Ajanta Pharma Limited | Approved | Yes | Yes | Not Listed | Manufactures a wide range of pharmaceuticals with FDA approvals. |
| Jubilant Generics Limited | Approved | Yes | Yes | Not Listed | Manufactures a wide range of pharmaceuticals with FDA approvals. |
| Anant Pharmaceutics | Not Listed | Yes | Yes | Not Listed | Operates GMP-compliant manufacturing facilities catering to regulated markets. |
TransData Nexus reviewed the regulatory standing of 10 leading Azithromycin exporters from India. 7 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Azithromycin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs), including Azithromycin. The city hosts over 800 pharmaceutical companies, such as Dr. Reddy's Laboratories and Aurobindo Pharma, which are integral to the supply chain of bulk drugs. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capacity for research and development in pharmaceuticals.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with major companies like Zydus Cadila and Torrent Pharmaceuticals operating in this region. Vadodara, in particular, is home to Century Pharma Ltd., a manufacturer of Azithromycin Dihydrate API, underscoring the area's significance in both API and finished dosage form production.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceuticals, leveraging its proximity to major ports and international airports. This region houses numerous pharmaceutical companies, including Cipla Limited, which is among the top exporters of Azithromycin. Cipla's extensive manufacturing facilities and strategic location facilitate efficient distribution to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Located in Himachal Pradesh, the Baddi-Nalagarh region has emerged as a prominent pharmaceutical manufacturing zone, partly due to favorable tax incentives. Baddi is home to over 1,000 pharmaceutical manufacturing units, making it Asia's largest pharmaceutical hub. Companies like Cipla and Dr. Reddy's Laboratories have established significant operations here, contributing to the production and export of various pharmaceuticals, including Azithromycin.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of suppliers, such as Century Pharma Ltd. in Vadodara and Cipla Limited in Mumbai, to ensure consistent quality and regulatory adherence.
- Leverage Tax Incentives: Consider sourcing from manufacturers in tax incentive zones like Baddi to potentially reduce procurement costs.
- Monitor Export Performance: Prioritize suppliers with a strong export track record to destinations like the United States and Nigeria, indicating reliability and global compliance standards.
By strategically sourcing from these established pharmaceutical clusters, TransData Nexus can optimize its supply chain for Azithromycin, ensuring quality, cost-effectiveness, and resilience.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Azithromycin exporters from India
Cipla Limited — Cipla acquires Ivia Beaute’s personal care brands
Cipla Limited acquired the distribution and marketing business of Ivia Beaute Pvt Ltd for ₹130 crore, with an additional ₹110 crore as milestone-based consideration. This acquisition is part of Cipla’s strategy to expand its consumer health vertical. - IMPACT: This acquisition is not expected to directly impact Cipla's Azithromycin exports, as it focuses on expanding the company's consumer wellness portfolio.
Impact: This acquisition is not expected to directly impact Cipla's Azithromycin exports, as it focuses on expanding the company's consumer wellness portfolio.
Common Questions — Azithromycin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which azithromycin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, LINCOLN PHARMACEUTICALS LTD leads with 97 recorded shipments worth $19.2M. LUPIN LIMITED (220 shipments) and MICRO LABS LIMITED (110 shipments) are also established high-volume exporters.
Q How many azithromycin manufacturers are there in India?
India has 853 active azithromycin exporters with a combined export market of $184.3M across 15,000 shipments to 169 countries. The top 5 suppliers hold 32.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for azithromycin from India?
Average FOB unit price: $14.17 per unit, ranging from $0.01 to $7680.89. Average shipment value: $12.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 853 verified Indian exporters of Azithromycin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 169 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
853 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists